133  Plasmodium falciparum full life cycle and Plasmodium ovale liver stages in humanized mice.

132  A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria.

131  A novel multiple-stage antimalarial agent that inhibits protein synthesis.

130  A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates.

129  The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs.

128  A forward genetic screen identifies erythrocyte CD55 as essential for Plasmodium falciparum invasion.

127  Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial.

126  RIFINs are adhesins implicated in severe Plasmodium falciparum malaria.

125  Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidate.

124  The in vivo dynamics of antigenic variation in Trypanosoma brucei.

Free Images for Presentation: sunipix SUNIPIX